Carl Zeiss Meditec AG, the Germany-based medical technology solutions supplier, has acquired a 100% stake in Dorc Dutch Ophthalmic Research (aka D.O.R.C.), the Netherlands based supplier of equipment, instruments and liquids for ophthalmic surgery, from Eurazeo (f.k.a. Idinvest Partners), the France based private equity and venture capital firm. The transaction is valued at an enterprise value of approximately EUR 985m. The purchase price will be paid for primarily by available net liquidity of Carl Zeiss Meditec AG. In order to maintain operational flexibility, the company plans to seek a shareholder loan from Carl Zeiss AG in the amount of EUR 400m as part of the financing, with a duration of three years and market-standard conditions.
- Target – Dorc Dutch Ophthalmic Research Center b.v.
- Buyer – Carl Zeiss Meditec AG
- Seller – Eurazeo sa
